Company / Cost of Revenue
IMMUCELL CORP /DE/ Cost of Revenue History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$18.6M
FY2025
5-year range
$4.0M / $18.6M
FY2021-FY2025
Trend
+36.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has increased for 8 consecutive years, from $2M in FY2012 to $19M in FY2025.
Based on SEC 10-K filings.
$19M in FY2025 with a 10-year CAGR of +20.2%.
Increased from $11M to $19M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +20.2%
Key checks
Key Insights
- IMMUCELL CORP /DE/'s cost of revenue has grown for 8 consecutive years.
- In FY2025, cost of revenue increased 36.4% year-over-year.
- Lowest cost of revenue in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.6M | +36.4% |
| FY2024 | $13.6M | +24.6% |
| FY2023 | $10.9M | +164.8% |
| FY2017 | $4.1M | +3.7% |
| FY2016 | $4.0M | +35.0% |
| FY2015 | $2.9M | +26.2% |
| FY2014 | $2.3M | +1.7% |
| FY2013 | $2.3M | +10.3% |
| FY2012 | $2.1M | -1.1% |
| FY2011 | $2.1M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026